-
61
Optimal Operational Decision Making of Manufacturers and Authorized Remanufacturers with Patent Licensing under Carbon Cap-and-Trade Regulations
Published 2020-01-01“…Constrained by production capacity and the pressure to reduce emissions, many original equipment manufacturers (OEMs) authorize third-party remanufacturers (TPRs) to remanufacture patented products. We investigate the operational decisions of OEMs and authorized TPRs under carbon cap-and-trade regulations in a two-echelon supply chain. …”
Get full text
Article -
62
Comparison of the Effectiveness of Paracetamol and Ibuprofen in the Management of Patent Ductus Arteriosus in Preterm Neonates: A Randomized Controlled Trial
Published 2025-01-01Subjects: “…Patent ductus arteriosus…”
Get full text
Article -
63
Antithrombotic Therapy Duration after Patent Foramen Ovale Closure for Stroke Prevention: Impact on Long-Term Outcome
Published 2022-01-01“…The optimal duration of antithrombotic therapy (ATT) after patent foramen ovale (PFO) closure remains under debate. …”
Get full text
Article -
64
Fences on the Epistemological Prairie: A Settler Colonial Approach to “Religion and Science”
Published 2024-12-01Subjects: Get full text
Article -
65
-
66
A Retrospective Analysis of Self-Limiting Fever following Percutaneous Patent Foramen Ovale and Atrial Septal Defect Closure
Published 2024-01-01“…While percutaneous closure of patent foramen ovale (PFO) and atrial septal defect (ASD) are generally well-tolerated procedures, the development of postprocedure fever has been observed at a higher frequency than reported in the initial device trials. …”
Get full text
Article -
67
Explainable machine learning model for predicting decline in platelet count after interventional closure in children with patent ductus arteriosus
Published 2025-02-01Subjects: Get full text
Article -
68
Association of Slender Patent Ductus Arteriosus Combined With PFO Related to the Transient Ischemic Attack: A Rare Case Report
Published 2025-01-01Subjects: Get full text
Article -
69
Propriedade intelectual e difusão da inovação: mapeamento de registros de patentes de IFES do Nordeste
Published 2025-01-01Subjects: Get full text
Article -
70
Ensuring the technological independence of oil and gas companies using patent analytics on the example of companies producing liquefied natural gas
Published 2023-11-01Subjects: Get full text
Article -
71
How Significant Are Marine Invertebrate Collagens? Exploring Trends in Research and Innovation
Published 2024-12-01Subjects: “…patents…”
Get full text
Article -
72
Who owns the Atoms? Nanotechnology and Intellectual Property Rights
Published 2015-05-01Subjects: Get full text
Article -
73
Innovation in der Translation. Aspekte der Patentübersetzung am Beispiel der Relation Deutsch-Polnisch
Published 2025-02-01Subjects: “…patent document…”
Get full text
Article -
74
Impacts of Industry 4.0 in developed countries & BRICs
Published 2025-02-01Subjects: Get full text
Article -
75
A QUALIDADE DOS PRIVILÉGIOS PATENTÁRIOS CONCEDIDOS NO BRASIL SOB A ÓTICA DAS AÇÕES JUDICIAIS DE NULIDADE DE PATENTES
Published 2021-06-01Subjects: Get full text
Article -
76
THE CREATION OF NEW INFRASTRUCTURE UNITS OF THE RESEARCH ORGANIZATION
Published 2017-07-01Subjects: Get full text
Article -
77
Transcatheter Closure of Patent Ductus Arteriosus in Elderly Patients: Initial and One-Year Follow-Up Results—Do We Have the Proper Device?
Published 2020-01-01“…Objectives. Patent ductus arteriosus (PDA) in elderly patients is an uncommon anomaly, and the duct itself is often calcified and fragile; therefore, transcatheter closure is more difficult. …”
Get full text
Article -
78
Left Pulmonary Artery Stenting for Left Pulmonary Artery Stenosis Following Patent Ductus Arteriosus Device Closure: Case Series and Review of the Literature
Published 2024-01-01“…Percutaneous device occlusion is currently the standard of care for most cases of patent ductus arteriosus (PDA). Albeit infrequent, device-related left pulmonary artery (LPA) stenosis is a known complication of this procedure, occasionally requiring stent placement to relieve the obstruction. …”
Get full text
Article -
79
Eliminating Postoperative Nausea and Vomiting in Outpatient Surgery with Multimodal Strategies including Low Doses of Nonsedating, Off-Patent Antiemetics: Is “Zero Tolerance“ Achievable?
Published 2007-01-01“…At the end of surgery, ondansetron (4 mg i.v., now off-patent) is added. Rescue therapy consists of avoiding unnecessary repeat doses of drugs acting by the same mechanism: haloperidol 2 mg i.v. …”
Get full text
Article -
80
Patent foramen ovale in young stroke patients: diagnostic challenge and a new approach to the secondary prevention (a case report and review of literature)
Published 2018-06-01Subjects: “…patent foramen ovale…”
Get full text
Article